Last reviewed · How we verify

NCT04311814

The Valsalva Urethral Profile : a Measure to Assess Stress Urinary Incontinence

Completed NA Last updated 17 March 2020
What this trial tests

NA trial testing Maximum urethral closure pressure during Valsalva (v-MUCP) in Stress Urinary Incontinence in 695 participants. Completed in 20 December 2019.

Timeline
15 February 2016
Primary endpoint
25 September 2019
20 December 2019

Quick facts

Lead sponsorPoissy-Saint Germain Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment695
Start date15 February 2016
Primary completion25 September 2019
Estimated completion20 December 2019

Drugs / interventions tested

Conditions studied

Sponsor

Poissy-Saint Germain Hospital

Who can join

18 and older, female only, with Stress Urinary Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical and paraclinical appraisal of stress urinary incontinence (SUI) is mainly based on the assessment of pelvic floor muscles (PFM) contraction and urethral mobility, the measurement of the maximum urethral closure pressure (MUCP) at rest by urethral pressure profilometry (UPP) and the measurement of the Valsalva leak point pressure (VLPP). Currently, MUCP and VLPP cannot be used for diagnosing SUI because they appear to be moderately correlated with the severity of SUI. The lack of a specific SUI biomarker could be the explanation for the poor predictive value of urodynamics and the ongoing debate on whether urodynamic testing before surgery has benefits. Our main objective was to study the value of a new urodynamic parameter in the diagnosis of female SUI: the Valsalva urethral profile (VUP)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stress Urinary Incontinence

Currently open trials in the same condition.

Other Poissy-Saint Germain Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04311814.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing